The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
14-day continuous infusion ifosfamide in advanced refractory sarcomas.
Arun S. Singh
No relevant relationships to disclose
Kamalesh Kumar Sankhala
No relevant relationships to disclose
Arnob Mukherjee
No relevant relationships to disclose
Vivek Narasimha
No relevant relationships to disclose
Bartosz Chmielowski
No relevant relationships to disclose
Doris V. Quon
No relevant relationships to disclose
Vicky Chua
No relevant relationships to disclose
Sant P. Chawla
No relevant relationships to disclose